SARS-CoV Spike Produits
(SARS-Coronavirus Spike Protein (SARS-CoV S))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories SARS-CoV Spike en vedette
SARS-CoV Spike Anticorps
High quality antibodies with extensive validation data.
SARS-CoV Spike Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
SARS-CoV Spike recommandé Anticorps
- (1)
- (2)
- (5)
- (3)
- (6)
- (1)
SARS-CoV Spike recommandé Protéines
- (4)
- (1)
- (3)
- (2)
Dernières publications sur nos produits SARS-CoV Spike
: "Small form factor flow virometer for SARS-CoV-2." dans: , Vol. 13, Issue 3, pp. 1609-1619, (2022) (PubMed).: "Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry." dans: Nature communications, Vol. 12, Issue 1, pp. 250, (2021) (PubMed).
: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." dans: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).
: "An antigen microarray protocol for COVID-19 serological analysis." dans: STAR protocols, Vol. 2, Issue 3, pp. 100815, (2021) (PubMed).
: "A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters. ..." dans: Nature communications, Vol. 12, Issue 1, pp. 6277, (2021) (PubMed).
: "Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats." dans: BMC infectious diseases, Vol. 21, Issue 1, pp. 871, (2021) (PubMed).
: "38" dans: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)
: "Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV." dans: Nature communications, Vol. 11, Issue 1, pp. 1620, (2020) (PubMed).
: "Evaluate Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity by Pseudoviral Particles." dans: Journal of medical virology, (2020) (PubMed).
: "Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. ..." dans: Emerging infectious diseases, Vol. 26, Issue 6, (2020) (PubMed).
Avez-vous cherché autre chose?
- SARS-CoV S2
- SARS-CoV S1
- SARS-CoV NSP3
- SARS-CoV E2 Glycoprotein
- SARS-Coronavirus Nucleocapsid Protein
- SARS-Coronavirus Nonstructural Protein 8
- SARS-Coronavirus Membrane Protein
- SARS-Coronavirus Envelope Protein
- SARS Associated Spike Mosaic S
- SARNP
- SARM1
- SARDH
- Sarcolemma Associated Protein
- Sarcalumenin
- SAR1B
- SAR1A
- Sar1
- SAPS2
- SAPS1
- SAPCD2
- SARS-CoV-2
- SARS-CoV-2 (CB6 Biosimilar)
- SARS-CoV-2 Envelope
- SARS-CoV-2 Membrane Protein
- SARS-CoV-2 NSP1
- SARS-CoV-2 NSP10
- SARS-CoV-2 NSP12 (RdRP)
- SARS-CoV-2 NSP13
- SARS-CoV-2 NSP14
- SARS-CoV-2 NSP15
- SARS-CoV-2 NSP16
- SARS-CoV-2 NSP2
- SARS-CoV-2 NSP3
- SARS-CoV-2 NSP4
- SARS-CoV-2 NSP5 (3CL-Pro)
- SARS-CoV-2 NSP6
- SARS-CoV-2 NSP7
- SARS-CoV-2 NSP8
- SARS-CoV-2 NSP9
- SARS-CoV-2 Nucleocapsid